| Literature DB >> 19342973 |
Jaleh Shojaeian1, Mahmood Jeddi-Tehrani, Pouneh Dokouhaki, Ahmad Reza Mahmoudi, Roya Ghods, Mahmood Bozorgmehr, Shohreh Nikoo, Ali Ahmad Bayat, Mohammad Mehdi Akhondi, Mahyar Ostadkarampour, Simin Rezania, Amir Hassan Zarnani.
Abstract
To develop an efficient dendritic cell (DC)-based immunotherapy protocol, we examined whether simultaneous pulsing of DCs with a given antigen and a third-party antigen could enhance their antigen presentation capacity. Purified splenic DCs of Balb/c mice were pulsed separately with immunoglobulin G, ovalbumin, conalbumin, P15 peptide of Mycobacterium tuberculosis, and prostate-specific antigen or double combinations of the aforementioned antigens. In some settings, DCs pulsed with 1 antigen were mixed equally with those pulsed with another antigen. Antigen-pulsed DCs were injected into the footpad of syngeneic mice and proliferation of whole, CD4 and CD8 depleted lymph node cells was measured after restimulation with cognate antigen. Antigen-specific production of interferon-gamma (IFNgamma) was tested in culture supernatants. Frequency of responding lymph node cells was determined by IFNgamma enzyme-linked immunosorbent spot assay. Our results showed that copulsing of DCs with 2 unrelated antigens increased the capacity of DCs to induce antigen-specific T-cell proliferation against both antigens up to 16-fold. Injection of 2 populations of DCs each pulsed with a different antigen, increased proliferation of primed T cells significantly as well. Both CD4 and CD8 depleted populations showed vigorous proliferative response in copulsing system. In addition, copulsing of DCs with 2 antigens resulted in higher frequency of antigen-specific responding cells and significantly more IFNgamma production. Our results clearly showed that unrelated peptides and proteins could be used to enhance efficacy of DC-based vaccines and in this system, each antigen served to help the other one, a condition that we termed as "mutual helper effect."Entities:
Mesh:
Substances:
Year: 2009 PMID: 19342973 DOI: 10.1097/CJI.0b013e31819aa31e
Source DB: PubMed Journal: J Immunother ISSN: 1524-9557 Impact factor: 4.456